<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-molecules-26-00438">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gootz</surname>
    <given-names>T.D.</given-names>
   </name>
   <name>
    <surname>Zaniewski</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Haskell</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Schmieder</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Tankovic</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Girard</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Courvalin</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Polzer</surname>
    <given-names>R.J.</given-names>
   </name>
  </person-group>
  <article-title>Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>1996</year>
  <volume>40</volume>
  <fpage>2691</fpage>
  <lpage>2697</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.40.12.2691</pub-id>
  <pub-id pub-id-type="pmid">9124824</pub-id>
 </element-citation>
</ref>
